Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M; RELAXin in Acute Heart Failure (RELAX-AHF) Investigators. Teerlink JR, et al. Among authors: schumacher c. Lancet. 2013 Jan 5;381(9860):29-39. doi: 10.1016/S0140-6736(12)61855-8. Epub 2012 Nov 7. Lancet. 2013. PMID: 23141816 Clinical Trial.
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld L, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Prescott MF, Edwards C, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin T, Teerlink JR; RELAX-AHF Investigators. Metra M, et al. Among authors: schumacher c. J Am Coll Cardiol. 2013 Jan 15;61(2):196-206. doi: 10.1016/j.jacc.2012.11.005. J Am Coll Cardiol. 2013. PMID: 23273292 Free article. Clinical Trial.
Glutamine promotes human CD8+ T cells and counteracts imiquimod-induced T cell hyporesponsiveness.
Bopp L, Martinez ML, Schumacher C, Seitz R, Arana MH, Klapproth H, Lukas D, Oh JH, Neumayer D, Lackmann JW, Mueller S, von Stebut E, Brachvogel B, Brodesser S, Klein Geltink RI, Fabri M. Bopp L, et al. Among authors: schumacher c. iScience. 2024 Apr 18;27(5):109767. doi: 10.1016/j.isci.2024.109767. eCollection 2024 May 17. iScience. 2024. PMID: 38736545 Free PMC article.
Postoperative Pain Following Eye Enucleation: A Prospective Observational Study.
Leister N, Löser J, Gostian AO, Gostian M, Rokohl AC, Fieber MA, Alkan D, Schumacher C, Löw V, Gordon E, Böttiger BW, Heindl LM. Leister N, et al. Among authors: schumacher c. Medicina (Kaunas). 2024 Apr 9;60(4):614. doi: 10.3390/medicina60040614. Medicina (Kaunas). 2024. PMID: 38674260 Free PMC article.
[Workplace-associated fever].
Schumacher C, Clarenbach C, Dressel H. Schumacher C, et al. Ther Umsch. 2024 Feb;81(1):24-28. Ther Umsch. 2024. PMID: 38655831 Review. German.
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial.
Mulatero P, Wuerzner G, Groessl M, Sconfienza E, Damianaki A, Forestiero V, Vogt B, Brunner H, Gerlock T, Steele R, Schumacher C. Mulatero P, et al. Among authors: schumacher c. EClinicalMedicine. 2024 Apr 6;71:102576. doi: 10.1016/j.eclinm.2024.102576. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38618204 Free PMC article.
Should we be testing for Mycoplasma genitalium on initial presentation? Trends in persistent/recurrent urethritis among men presenting for care in STD clinics, 2015-2019, STD Surveillance Network (SSuN).
Llata E, Tromble E, Schumacher C, Huspeni D, Asbel L, Pathela P, Kohn R, Kerani RP, Barbee L, Bachman L. Llata E, et al. Among authors: schumacher c. Sex Transm Dis. 2024 Apr 11. doi: 10.1097/OLQ.0000000000001975. Online ahead of print. Sex Transm Dis. 2024. PMID: 38602771
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500. Online ahead of print. J Clin Oncol. 2024. PMID: 38537155
536 results